We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
New innovations: Therapeutic opportunities for intellectual disabilities.
- Authors
Picker, Jonathan D.; Walsh, Christopher A.
- Abstract
Intellectual disability is common and is associated with significant morbidity. Until the latter half of the 20th century, there were no efficacious treatments. Following initial breakthroughs associated with newborn screening and metabolic corrections, little progress was made until recently. With improved understanding of genetic and cellular mechanisms, novel treatment options are beginning to appear for a number of specific conditions. Fragile X and tuberous sclerosis offer paradigms for the development of targeted therapeutics, but advances in understanding of other disorders such as Down syndrome and Rett syndrome, for example, are also resulting in promising treatment directions. In addition, better understanding of the underlying neurobiology is leading to novel developments in enzyme replacement for storage disorders and adjunctive therapies for metabolic disorders, as well as potentially more generalizable approaches that target dysfunctional cell regulation via RNA and chromatin. Physiologic therapies, including deep brain stimulation and transcranial magnetic stimulation, offer yet another direction to enhance cognitive functioning. Current options and evolving opportunities for the intellectually disabled are reviewed and exemplified. Ann Neurol 2013;74:382-390
- Publication
Annals of Neurology, 2013, Vol 74, Issue 3, p382
- ISSN
0364-5134
- Publication type
Article
- DOI
10.1002/ana.24002